AMA-positive hepatitis induced by the SARS-CoV-2 vaccine

Rev Esp Enferm Dig. 2022 May;114(5):297-298. doi: 10.17235/reed.2022.8533/2021.

Abstract

We present the case of a 56-year-old female admitted to our centre for hepatitis. She had recieved the first dose of the BNT162b2 vaccine against SARS-CoV-2 10 days before the admission. Etiologic study was negative. The patient was diagnosed with vaccine-induced hepatitis.

Publication types

  • Case Reports

MeSH terms

  • BNT162 Vaccine* / adverse effects
  • COVID-19* / prevention & control
  • Chemical and Drug Induced Liver Injury*
  • Female
  • Hepatitis*
  • Humans
  • Middle Aged

Substances

  • BNT162 Vaccine